Report Overview
Gabapentin is a pharmaceutical drug primarily used to treat neurological disorders such as epilepsy and neuropathic pain.
It functions by affecting nerve signals in the brain and spinal cord, helping to manage seizures and chronic pain conditions.
Gabapentin is commonly available in capsule, tablet, and oral solution forms and is frequently prescribed for conditions like restless legs syndrome and postherpetic neuralgia.
Market Analysis
The global Gabapentin Market was valued at US$ 2,145.3 million in 2024 and is projected to reach US$ 3,875.6 million by 2032, reflecting a CAGR of 7.6% during the forecast period (2024-2032).
Historically, the market stood at US$ 1,586.6 million in 2022, showcasing steady growth driven by increased diagnoses of neurological conditions and expanding applications of Gabapentin.
Regional Analysis
North America
Europe
Asia-Pacific
South America
Middle East & Africa
Competitor Analysis
TEVA Pharmaceuticals
Mylan
Novartis
Market Segmentation
By
Application:
Epilepsy
Neuropathic Pain
Restless Legs Syndrome (RLS)
Others
By Type:
Capsules
Tablets
